For the year ending 2025-12-31, MIRA has $11,093,605 in assets. $702,068 in debts. $6,346,921 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 6,346,921 | |||
| Prepaid expenses | 28,146 | |||
| Short-term investment, at fair value related party | 4,683,099 | |||
| Total current assets | 11,058,166 | |||
| Related party receivable | 35,439 | |||
| Total assets | 11,093,605 | |||
| Trade accounts payable and accrued liabilities | 129,203 | |||
| Due to related party | 572,865 | |||
| Total current liabilities | 702,068 | |||
| Total liabilities | 702,068 | |||
| Common stock, 0.0001 par value 100,000,000 shares authorized, 41,938,587 and 16,560,852 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 4,194 | |||
| Additional paid-in capital | 49,967,549 | |||
| Accumulated deficit | -39,580,206 | |||
| Total stockholders equity | 10,391,537 | |||
| Total liabilities and stockholders equity | 11,093,605 | |||
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)